Skip to main content
. Author manuscript; available in PMC: 2019 Oct 28.
Published in final edited form as: J Heart Lung Transplant. 2019 Aug 8;38(10):1042–1055. doi: 10.1016/j.healun.2019.08.001

Table 2.

Known Causes of Death for Adult Lung Transplant Recipients (Deaths: January 1995–June 2018)

Cause of death 0–30 days
(n = 3,361)
31 days–1 year
(n = 6,489)
>1 year–3 years
(n = 6,775)
>3 years–5 years
(n = 4,177)
>5 years–10 years
(n = 5,404)
>10 years
(n = 2,364)

OB/BOS   5 (0.1%)    278 (4.3%) 1,728 (25.5%) 1,224 (29.3%) 1,321 (24.4%) 497 (21.0%)
Acute rejection   92 (2.7%)    121 (1.9%)    107 (1.6%)   31 (0.7%)   27 (0.5%)   5 (0.2%)
Lymphoma  1 (0.0%)    129 (2.0%)    110 (1.6%)   60 (1.4%)    100 (1.9%)   69 (2.9%)
Malignancy, other  6 (0.2%)    198 (3.1%)    595 (8.8%)    535 (12.8%)    831 (15.4%) 354 (15.0%)
CMV 0    122 (1.9%)   57 (0.8%)   9 (0.2%)   7 (0.1%)   1 (0.0%)
Infection, non-CMV 579 (17.2%) 2,149 (33.1%) 1,390 (20.5%)    718 (17.2%)    888 (16.4%) 382 (16.2%)
Graft failure 738 (22.0%) 1,046 (16.1%) 1,306 (19.3%)    750 (18.0%)    869 (16.1%) 363 (15.4%)
Cardiovascular 440 (13.1%)    379 (5.8%)    302 (4.5%)    197 (4.7%)    334 (6.2%) 161 (6.8%)
Technical 394 (11.7%)    206 (3.2%)   58 (0.9%)   22 (0.5%)   40 (0.7%)   15 (0.6%)
Multiple organ failure 488 (14.5%)    864 (13.3%)    358 (5.3%)    175 (4.2%)    249 (4.6%) 120 (5.1%)
Other 618 (18.4%)    997 (15.4%)    764 (11.3%)    456 (10.9%)    738 (13.7%) 397 (16.8%)

Abbreviations: BOS, bronchiolitis obliterans syndrome; CMV, cytomegalovirus; OB, obliterative bronchiolitis